World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
26514
World Ranking
9816
National Ranking
5047

Overview

George J. Bosl is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on medicine, with particular emphasis on surgery, pulmonary and respiratory medicine, hematology, reproductive medicine, and neurology.

Their work revolves around several key topics including testicular diseases and treatments, ovarian cancer diagnosis and treatment, neuroblastoma research and treatments, sarcoma diagnosis and treatment, multiple myeloma research and treatments, lung cancer research studies, and acute myeloid leukemia research.

George J. Bosl has contributed to numerous publications across various journals. Frequent venues for their work include:

  • Journal of Clinical Oncology
  • The Annals of Thoracic Surgery
  • Journal of Clinical Investigation
  • The Oncologist
  • JCO Precision Oncology

Significant recent papers authored or co-authored by George J. Bosl are:

  • "Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor," 2020, Journal of Clinical Investigation
  • "Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors," 2020, Journal of Clinical Oncology
  • "Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors," 2021, The Oncologist
  • "Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis Pairs," 2020, JCO Precision Oncology
  • "Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease," 2024, Journal of Clinical Oncology

Frequent collaborators include:

  • Samuel A. Funt
  • Darren R. Feldman
  • Joel Sheinfeld
  • Deaglan Joseph McHugh
  • Dean F. Bajorin

Best Publications

  • Testicular Germ-Cell Cancer

    George J. Bosl;Robert J. Motzer

  • Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol Design

    Ting-Chao Chou;Robert J. Motzer;Youzhi Tong;George J. Bosl

  • Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

    G. Varuni Kondagunta;Jennifer Bacik;Alessia Donadio;Dean Bajorin

  • Medical Treatment of Advanced Testicular Cancer

    Darren R. Feldman;George J. Bosl;Joel Sheinfeld;Robert J. Motzer

  • Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors.

    Robert J. Motzer;Alison Amsterdam;Alison Amsterdam;Victor Prieto;Victor Prieto;Joel Sheinfeld;Joel Sheinfeld

  • Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.

    Robert J. Motzer;Craig J. Nichols;Kim A. Margolin;Jennifer Bacik

  • Down-Regulation of Stem Cell Genes, Including Those in a 200-kb Gene Cluster at 12p13.31, Is Associated with In vivo Differentiation of Human Male Germ Cell Tumors

    James E. Korkola;Jane Houldsworth;Rajendrakumar S.V. Chadalavada;Adam B. Olshen

  • Raynaud's Phenomenon: A Common Toxicity After Combination Chemotherapy for Testicular Cancer

    Nicholas J. Vogelzang;George J. Bosl;Kay Johnson;B.J. Kennedy

  • A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.

    G J Bosl;N L Geller;D Bajorin;S P Leitner

  • Paclitaxel, Ifosfamide, and Cisplatin Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Cancer

    Robert J. Motzer;Joel Sheinfeld;Madhu Mazumdar;Manjit Bains

  • Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

    Hege S. Haugnes;George J. Bosl;Hink Boer;Jourik A. Gietema

  • Teratoma with malignant transformation in germ cell tumors in men.

    Tauseef Ahmed;George J. Bosl;Steven I. Hajdu

  • Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.

    Howard I. Scher;Alan Yagoda;Harry W. Herr;Cora N. Sternberg

  • Chemotherapy for Teratoma With Malignant Transformation

    Alessia C. Donadio;Robert J. Motzer;Dean F. Bajorin;Philip W. Kantoff

  • VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.

    G J Bosl;R Gluckman;N L Geller;R B Golbey

  • Improved control of cisplatin‐induced emesis with high‐dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients

    Mark G. Kris;Richard J. Gralla;Leslie B. Tyson;Rebecca A. Clark

  • Sequential Dose-Intensive Paclitaxel, Ifosfamide, Carboplatin, and Etoposide Salvage Therapy for Germ Cell Tumor Patients

    Robert J. Motzer;Madhu Mazumdar;Joel Sheinfeld;Dean F. Bajorin

  • TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis

    Darren R. Feldman;Joel Sheinfeld;Dean F. Bajorin;Patricia Fischer

  • A method for assessing house staff workload as a function of length of stay.

    Timothy H. Dellit;Barbara Armas-Loughran;George J. Bosl;Kent A. Sepkowitz

  • Germ Cell Tumors

    Edward R. Laws;Jason P. Sheehan

Frequent Co-Authors

Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center
R. S. K. Chaganti
R. S. K. Chaganti Memorial Sloan Kettering Cancer Center
Nancy L. Geller
Nancy L. Geller National Institutes of Health
Harry W. Herr
Harry W. Herr Memorial Sloan Kettering Cancer Center
David G. Pfister
David G. Pfister Memorial Sloan Kettering Cancer Center
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Manjit S. Bains
Manjit S. Bains Memorial Sloan Kettering Cancer Center
Jatin P. Shah
Jatin P. Shah Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering studying Medicine in the USA, exploring related online degrees can expand your career opportunities in healthcare. Many accredited programs now offer flexible pathways for working professionals or students seeking alternatives to traditional medical school.

If you’re interested in mental health, accelerated msn psychiatric np programs provide a fast track to advanced nursing roles focused on psychiatric care. These programs can be ideal for those who want to specialize in mental health support and counseling.

An online health management degree offers essential skills in healthcare leadership and operations, opening doors to managerial roles in clinics, hospitals, or health organizations.

Budget is a concern for many students, so looking into the cheapest online mha programs and cheapest dnp degrees can make advanced education more accessible without sacrificing program quality.

These online pathways can help you launch or grow a career in healthcare, whether your interests are in clinical practice, mental health, or health administration.

Best Scientists Citing George J. Bosl

Trending Scientists

Recently Published Articles